Bambusa Therapeutics Completes Oversubscribed Series A-2 Financing

Leila Ahmed North America Legal Chronicle
Tagged:

Wilson Sonsini Goodrich & Rosati has advised Bambusa Therapeutics, Inc. Bambusa Therapeutics, Inc., a clinical-stage biotechnology company focusing on the development of next-generation bispecific antibodies for…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here